Michael Jay Ross

Insider Reports History

Location
Boston, MA
Signature
/s/ Chris Frankenfield, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Jay Ross:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Xilio Therapeutics, Inc. Director Stock Option (right to buy) 13.2K 15 Jun 2022 Direct

Insider Reports Filed by Michael Jay Ross

Symbol Company Period Transactions Value $ Form Type Role Filing Time
XLO Xilio Therapeutics, Inc. 15 Jun 2022 1 $0 4 Director 17 Jun 2022, 16:30
XLO Xilio Therapeutics, Inc. 21 Oct 2021 1 $0 4 Director 25 Oct 2021, 17:18
XLO Xilio Therapeutics, Inc. 21 Oct 2021 0 $0 3 Director 21 Oct 2021, 20:48